sigmoidal dose-response curve with graphpad prism 7.0 Search Results


originpro 9g  (OriginLab corp)
90
OriginLab corp originpro 9g
Originpro 9g, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoidal+dose-response+curve+with+graphpad+prism+7%2E0/pm37902787-697-5-7?v=OriginLab+corp
Average 90 stars, based on 1 article reviews
originpro 9g - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
cell titerglo  (Promega)
90
Promega cell titerglo
Cell Titerglo, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoidal+dose-response+curve+with+graphpad+prism+7%2E0/pm27737926-97-9-11?v=Promega
Average 90 stars, based on 1 article reviews
cell titerglo - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
regorafenib  (Selleck Chemicals)
94
Selleck Chemicals regorafenib
Characteristics of drug metabolism in the 3D bioprinted liver cancer cell model. Dose-effect curves of cisplatin (A) , sorafenib (B) , and <t>regorafenib</t> (C) in the 3DP-HepG2 and 2D-HepG2 models after 72 h of treatment. The mRNA expression of drug resistance genes in the 2D-HepG2 and 3DP-HepG2 models at 5, 10, and 15 days after 3D printing. (D) MRP1, (E) BCRP, (F) ACBC1, (G) MDR-1, (H) MRP2, and (I) EGFR mRNAs.
Regorafenib, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoidal+dose-response+curve+with+graphpad+prism+7%2E0/pmc07283506-81-37-38?v=Selleck+Chemicals
Average 94 stars, based on 1 article reviews
regorafenib - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
sorafenib  (Selleck Chemicals)
96
Selleck Chemicals sorafenib
Characteristics of drug metabolism in the 3D bioprinted liver cancer cell model. Dose-effect curves of cisplatin (A) , <t>sorafenib</t> (B) , and regorafenib (C) in the 3DP-HepG2 and 2D-HepG2 models after 72 h of treatment. The mRNA expression of drug resistance genes in the 2D-HepG2 and 3DP-HepG2 models at 5, 10, and 15 days after 3D printing. (D) MRP1, (E) BCRP, (F) ACBC1, (G) MDR-1, (H) MRP2, and (I) EGFR mRNAs.
Sorafenib, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoidal+dose-response+curve+with+graphpad+prism+7%2E0/pmc07283506-81-21-22?v=Selleck+Chemicals
Average 96 stars, based on 1 article reviews
sorafenib - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
ebola pseudovirus a549 cells  (Marburg GmbH)
90
Marburg GmbH ebola pseudovirus a549 cells
Characteristics of drug metabolism in the 3D bioprinted liver cancer cell model. Dose-effect curves of cisplatin (A) , <t>sorafenib</t> (B) , and regorafenib (C) in the 3DP-HepG2 and 2D-HepG2 models after 72 h of treatment. The mRNA expression of drug resistance genes in the 2D-HepG2 and 3DP-HepG2 models at 5, 10, and 15 days after 3D printing. (D) MRP1, (E) BCRP, (F) ACBC1, (G) MDR-1, (H) MRP2, and (I) EGFR mRNAs.
Ebola Pseudovirus A549 Cells, supplied by Marburg GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoidal+dose-response+curve+with+graphpad+prism+7%2E0/10__1021_slash_acs__jmedchem__0c00463-93-18-4?v=Marburg+GmbH
Average 90 stars, based on 1 article reviews
ebola pseudovirus a549 cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
fluorogenic substrate h-pro-phe-arg-amc 11295  (Bachem)
90
Bachem fluorogenic substrate h-pro-phe-arg-amc 11295
Characteristics of drug metabolism in the 3D bioprinted liver cancer cell model. Dose-effect curves of cisplatin (A) , <t>sorafenib</t> (B) , and regorafenib (C) in the 3DP-HepG2 and 2D-HepG2 models after 72 h of treatment. The mRNA expression of drug resistance genes in the 2D-HepG2 and 3DP-HepG2 models at 5, 10, and 15 days after 3D printing. (D) MRP1, (E) BCRP, (F) ACBC1, (G) MDR-1, (H) MRP2, and (I) EGFR mRNAs.
Fluorogenic Substrate H Pro Phe Arg Amc 11295, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoidal+dose-response+curve+with+graphpad+prism+7%2E0/us10501440-143-3-8?v=Bachem
Average 90 stars, based on 1 article reviews
fluorogenic substrate h-pro-phe-arg-amc 11295 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
fluorogenic substrate h-pro-phe-arg-amc i1295  (Bachem)
90
Bachem fluorogenic substrate h-pro-phe-arg-amc i1295
Characteristics of drug metabolism in the 3D bioprinted liver cancer cell model. Dose-effect curves of cisplatin (A) , <t>sorafenib</t> (B) , and regorafenib (C) in the 3DP-HepG2 and 2D-HepG2 models after 72 h of treatment. The mRNA expression of drug resistance genes in the 2D-HepG2 and 3DP-HepG2 models at 5, 10, and 15 days after 3D printing. (D) MRP1, (E) BCRP, (F) ACBC1, (G) MDR-1, (H) MRP2, and (I) EGFR mRNAs.
Fluorogenic Substrate H Pro Phe Arg Amc I1295, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sigmoidal+dose-response+curve+with+graphpad+prism+7%2E0/us11851418-152-3-8?v=Bachem
Average 90 stars, based on 1 article reviews
fluorogenic substrate h-pro-phe-arg-amc i1295 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of drug metabolism in the 3D bioprinted liver cancer cell model. Dose-effect curves of cisplatin (A) , sorafenib (B) , and regorafenib (C) in the 3DP-HepG2 and 2D-HepG2 models after 72 h of treatment. The mRNA expression of drug resistance genes in the 2D-HepG2 and 3DP-HepG2 models at 5, 10, and 15 days after 3D printing. (D) MRP1, (E) BCRP, (F) ACBC1, (G) MDR-1, (H) MRP2, and (I) EGFR mRNAs.

Journal: Frontiers in Oncology

Article Title: Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research

doi: 10.3389/fonc.2020.00878

Figure Lengend Snippet: Characteristics of drug metabolism in the 3D bioprinted liver cancer cell model. Dose-effect curves of cisplatin (A) , sorafenib (B) , and regorafenib (C) in the 3DP-HepG2 and 2D-HepG2 models after 72 h of treatment. The mRNA expression of drug resistance genes in the 2D-HepG2 and 3DP-HepG2 models at 5, 10, and 15 days after 3D printing. (D) MRP1, (E) BCRP, (F) ACBC1, (G) MDR-1, (H) MRP2, and (I) EGFR mRNAs.

Article Snippet: Both cell models were treated with different concentrations of cisplatin (Sigma) (0.01, 0.1, 1, 2.5, 5, 10, 20, and 100 μM), sorafenib (Selleck, Houston, USA) (0, 1, 0.625, 1.25, 2.5, 5, 10, 20, and 40 μM), or regorafenib (Selleck) (0, 1, 0.625, 1.25, 2.5, 5, 10, 20, and 40 μM) for 72 h. Cell growth was measured by the CCK8 assay, and dose-response curves were drawn using GraphPad 7.0.

Techniques: Expressing

Characteristics of drug metabolism in the 3D bioprinted liver cancer cell model. Dose-effect curves of cisplatin (A) , sorafenib (B) , and regorafenib (C) in the 3DP-HepG2 and 2D-HepG2 models after 72 h of treatment. The mRNA expression of drug resistance genes in the 2D-HepG2 and 3DP-HepG2 models at 5, 10, and 15 days after 3D printing. (D) MRP1, (E) BCRP, (F) ACBC1, (G) MDR-1, (H) MRP2, and (I) EGFR mRNAs.

Journal: Frontiers in Oncology

Article Title: Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research

doi: 10.3389/fonc.2020.00878

Figure Lengend Snippet: Characteristics of drug metabolism in the 3D bioprinted liver cancer cell model. Dose-effect curves of cisplatin (A) , sorafenib (B) , and regorafenib (C) in the 3DP-HepG2 and 2D-HepG2 models after 72 h of treatment. The mRNA expression of drug resistance genes in the 2D-HepG2 and 3DP-HepG2 models at 5, 10, and 15 days after 3D printing. (D) MRP1, (E) BCRP, (F) ACBC1, (G) MDR-1, (H) MRP2, and (I) EGFR mRNAs.

Article Snippet: Both cell models were treated with different concentrations of cisplatin (Sigma) (0.01, 0.1, 1, 2.5, 5, 10, 20, and 100 μM), sorafenib (Selleck, Houston, USA) (0, 1, 0.625, 1.25, 2.5, 5, 10, 20, and 40 μM), or regorafenib (Selleck) (0, 1, 0.625, 1.25, 2.5, 5, 10, 20, and 40 μM) for 72 h. Cell growth was measured by the CCK8 assay, and dose-response curves were drawn using GraphPad 7.0.

Techniques: Expressing